Prognostic value of lactate dehydrogenase in non-small cell lung cancer patients with brain metastases: a retrospective cohort study

BACKGROUND: At present, although there are some known molecular markers for the prognosis of non-small cell lung cancer (NSCLC) brain metastases, but there are still shortcomings in sensitivity and specificity. Lactate dehydrogenase (LDH) is one of the key enzymes involved in malignancy vital glycol...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuting, Lv, Jia, Lv, Juan, Li, Heng, Liu, Chao, Jiang, Hongmei, Zhang, Meng, Deng, Zhiyong, Li, Gaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745527/
https://www.ncbi.nlm.nih.gov/pubmed/36524070
http://dx.doi.org/10.21037/jtd-22-1502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745527/
https://www.ncbi.nlm.nih.gov/pubmed/36524070
http://dx.doi.org/10.21037/jtd-22-1502

Ejemplares similares